US Stock MarketDetailed Quotes

RENB Renovaro

Watchlist
  • 0.537
  • +0.005+0.88%
Close Nov 1 16:00 ET
  • 0.510
  • -0.027-4.94%
Post 20:01 ET
86.81MMarket Cap-639P/E (TTM)

About Renovaro Company

Renovaro, Inc. is a pre-clinical stage biotechnology company, which engages in the development of genetically modified cellular and immune-therapy technologies used for the treatment of infectious diseases and cancer. Its pipeline consists of ENOB-HV-01, ENOB- HV-11, ENOB-HV-12, ENOB-DB-01, ENOB-DC-01, ENOB-DC-11, and ENOB-DC-21. The company was founded by Rene Sindlev and Serhat Gumrukcu on January 18, 2011 and is headquartered in Los Angeles, CA.

Company Profile

SymbolRENB
Company NameRenovaro
Listing DateDec 10, 2018
Founded2011
CEOMr. David Weinstein
MarketNASDAQ
Employees25
Fiscal Year Ends06-30
Address2080 Century Park East,Suite 906
CityLos Angeles
ProvinceCalifornia
CountryUnited States of America
Zip Code90067
Phone1-305-918-1980
Websitehttp://renovarobio.com

Company Executives

  • Name
  • Position
  • Salary
  • David Weinstein
  • Chief Executive Officer and Director
  • --
  • Simon Tarsh
  • Interim Chief Financial Officer and Principal Accounting Officer
  • --
  • Francois Binette
  • Managing Director and President
  • 881.57K
  • Dr. Mark A. Collins, PhD
  • Director
  • --
  • Maurice van Tilburg
  • Director
  • --
  • Douglas W. Calder
  • Director
  • --
  • James A. Mcnulty, C.P.A.
  • Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data